Roberts, Glore & Co’s Ambev ABEV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABEV
SCP
NAMI
BIP
ETC
Roberts, Glore & Co's ABEV Position: Q2 2026 in Review
Roberts, Glore & Co held its Ambev (ABEV) position steady in Q2 2026 at 28,880 shares worth $90.7K. The position accounts for 0.02% of the portfolio, ranked #246.
Roberts, Glore & Co first reported a position in ABEV in Q1 2020 and has held it in 26 quarters since. The position peaked at $113K in Q2 2021. 404 funds tracked by Wall St. Rank hold ABEV as of Q2 2026.
- Roberts, Glore & Co held 28,880 shares of Ambev worth $90.7K as of Q2 2026.
- Roberts, Glore & Co left its Ambev share count unchanged in Q2 2026.
- Ambev made up 0.02% of Roberts, Glore & Co's portfolio in Q2 2026, its #246 holding.
- Roberts, Glore & Co first reported a position in Ambev in Q1 2020 and has held it in 26 quarters since.
- Roberts, Glore & Co's Ambev position peaked at $113K in Q2 2021.
- 404 funds tracked by Wall St. Rank held Ambev as of Q2 2026.
Based on Roberts, Glore & Co's 13F filing for Q2 2026, filed 11 Aug 2026.